Nisa Investment Advisors’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.41K Hold
77
﹤0.01% 2342
2025
Q4
$7.49K Buy
77
+4
+5% +$343 ﹤0.01% 2343
2025
Q3
$5.2K Hold
73
﹤0.01% 2431
2025
Q2
$4.37K Hold
73
﹤0.01% 2473
2025
Q1
$3.83K Sell
73
-50
-41% -$2.81K ﹤0.01% 2313
2024
Q4
$6.76K Hold
123
﹤0.01% 2213
2024
Q3
$6.19K Buy
123
+40
+48% +$1.84K ﹤0.01% 2183
2024
Q2
$3.65K Buy
83
+5
+6% +$213 ﹤0.01% 2304
2024
Q1
$3.43K Buy
78
+11
+16% +$486 ﹤0.01% 2159
2023
Q4
$3.18K Sell
67
-300
-82% -$12.6K ﹤0.01% 2155
2023
Q3
$16.3K Hold
367
﹤0.01% 2071
2023
Q2
$17.5K Hold
367
﹤0.01% 2139
2023
Q1
$14K Hold
367
﹤0.01% 2096
2022
Q4
$10K Buy
367
+17
+5% +$486 ﹤0.01% 2201
2022
Q3
$11K Sell
350
-386
-52% -$13.4K ﹤0.01% 2169
2022
Q2
$25K Hold
736
﹤0.01% 1981
2022
Q1
$33K Hold
736
﹤0.01% 1944
2021
Q4
$29K Sell
736
-5,730
-89% -$231K ﹤0.01% 1858
2021
Q3
$217 Sell
6,466
-2,659
-29% -$90.4K ﹤0.01% 1372
2021
Q2
$268 Hold
9,125
﹤0.01% 1317
2021
Q1
$235 Hold
9,125
﹤0.01% 1432
2020
Q4
$208K Buy
9,125
+6,216
+214% +$144K ﹤0.01% 1449
2020
Q3
$62K Buy
+2,909
New +$65.3K ﹤0.01% 1718

Other funds holding IRMD

Nisa Investment Advisors's IRMD Position: Q1 2026 in Review

Nisa Investment Advisors held its iRadimed (IRMD) position steady in Q1 2026 at 77 shares worth $7.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2342.

Nisa Investment Advisors first reported a position in IRMD in Q3 2020 and has held it in 23 quarters since. The position peaked at $208K in Q4 2020. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Nisa Investment Advisors held 77 shares of iRadimed worth $7.41K as of Q1 2026.
  • Nisa Investment Advisors left its iRadimed share count unchanged in Q1 2026.
  • iRadimed made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2342 holding.
  • Nisa Investment Advisors first reported a position in iRadimed in Q3 2020 and has held it in 23 quarters since.
  • Nisa Investment Advisors's iRadimed position peaked at $208K in Q4 2020.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.